Back
Aurinia Pharmaceuticals Stock Price Chart

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Buy
56
AUPH
Aurinia Pharmaceuticals
Last Price:
$7.85
Seasonality Move:
-3.28%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
Aurinia Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.05 | Sell |
20-day SMA: | 8.03 | Sell |
50-day SMA: | 8.07 | Sell |
200-day SMA: | 7.72 | Buy |
8-day EMA: | 8 | Sell |
20-day EMA: | 8.01 | Sell |
50-day EMA: | 8.03 | Sell |
200-day EMA: | 7.76 | Buy |
Aurinia Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 44.68 | Sell |
Chaikin Money Flow: | 1080585 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.67 - 8.19) | Sell |
Bollinger Bands (100): | (7.72 - 8.54) | Sell |
Aurinia Pharmaceuticals Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 7.85 while AUPH 8-day simple moving average is 8.05, which is a Sell signal.
-
The stock price of AUPH is 7.85 while Aurinia Pharmaceuticals 20-day SMA is 8.03, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day simple moving average is 8.07 while AUPH share price is 7.85, making it a Sell technically.
-
AUPH stock price is 7.85 and Aurinia Pharmaceuticals 200-day simple moving average is 7.72, creating a Buy signal.
AUPH Technical Analysis vs Fundamental Analysis
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a BuyThe current Aurinia Pharmaceuticals [AUPH] share price is $7.85. The Score for AUPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
1.1B
Price in USD:
7.85
Share Volume:
2.1M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
10.67
52-Week Low:
5.11
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?The Aurinia Pharmaceuticals stock price is 7.85 USD today.
-
Will AUPH stock go up or go down?Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Aurinia Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is not overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
-
Aurinia Pharmaceuticals share price is 7.85 while AUPH 8-day exponential moving average is 8.00, which is a Sell signal.
-
The stock price of AUPH is 7.85 while Aurinia Pharmaceuticals 20-day EMA is 8.01, which makes it a Sell.
-
Aurinia Pharmaceuticals 50-day exponential moving average is 8.03 while AUPH share price is 7.85, making it a Sell technically.
-
AUPH stock price is 7.85 and Aurinia Pharmaceuticals 200-day simple moving average is 7.76, creating a Buy signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.18 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
-
AUPH Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Aurinia Pharmaceuticals is a Buy
-
Aurinia Pharmaceuticals Relative Strength Index (RSI) is 44.68, which suggest Aurinia Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Aurinia Pharmaceuticals is (7.67 - 8.19), which suggest Aurinia Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Aurinia Pharmaceuticals is (7.72 - 8.54), which suggest Aurinia Pharmaceuticals is a Sell
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.